Tag: entrepreneurs
-
Cystic Fibrosis Start-Up Raises $111M in New Funds
A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds.
-
Infographic – Chill Descends on Q1 Venture Funds
The rise in venture funds invested in start-up businesses worldwide over the past two years took a noticeable downturn in the first three months of 2022.
-
Biotech Start-Up Begins Longevity Therapy Work
A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process.
-
Preclinical Tests Show Antibody Stops Covid-19 Variants
Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2.
-
Synthetic Bio Companies Partner on Therapeutic Microbes
A developer of therapies from engineered microbes is collaborating with a synthetic biology components company on tools to create engineered gut bacteria.
-
Biotech, Synthetic Bio Companies Partner on T-Cell Therapies
A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics.
-
NASA Supporting Electric Alternative to Rocket Launch
A company creating an electric-powered launch technology says NASA agreed to a test later this year of a space satellite launched in low earth orbit.
-
Trial to Test AI-Designed Cancer Antibody Therapy
A clinical trial is set to begin evaluating a synthetic antibody treatment for solid tumor cancer designed with machine learning algorithms.
-
Biotech, University Partner on Mammal Hibernation Genomics
A biotechnology company discovering new drugs based on animal genomics is partnering with a university lab on research in mammal hibernation and adaption.
-
Trial Set for Respiratory Disease Nasal Spray Vaccine
A clinical trial is about to begin enrolling participants to test a vaccine given as a nasal spray protecting against respiratory syncytial virus, or RSV.